The effect of a comprehensive Precision Health application on markers of Type 2 Diabetes

Not Applicable

• Conditions: Type 2 Diabetes Mellitus; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12622000668707
• Lead Sponsor: Avondale University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-05-06
• Last Update Posted: 16 May 2022

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Individuals aged 35 to 65yrs who have been determined to meet the following criteria:
They have a:
A diagnosis of type 2 diabetes within the last 24 months and are not currently taking insulin
Classification of pre-diabetes by a medical practitioner

Exclusion Criteria

Currently experiencing heart failure, or has a previous diagnosis of heart failure
Pregnant, breastfeeding or planning pregnancy in the next 12-18 weeks
Once deemed eligible for the study, unwilling to wait up to 11 weeks to enter the program
Currently taking warfarin or another anti-coagulant
Any other contraindications identified by the individuals medical practitioner

Study & Design

• Study Type: Interventional
• Study Design: Not specified